Skip to main content

Table 2 Intervention characteristics of trials for each evaluation endpoint in the network meta-analysis

From: Effectiveness comparisons of various therapies for FIGO stage IB2/IIA2 cervical cancer: a Bayesian network meta-analysis

Treatment

Overall survival

Relapse

Trials

aEvents/Patients

%

Trials

bEvents/Patients

%

CCRT

1

237/317

74.8

1

43/317

13.6

RS

7

338/468

72.2

6

175/493

35.5

CCRT+RS

3

156/191

81.7

2

37/108

34.3

NACT+RS

8

512/730

70.1

6

106/593

17.9

RT + RS

4

173/227

76.2

3

41/173

23.7

RT

4

276/409

67.5

3

68/266

25.6

Total

 

1692/2342

72.2

 

470/1950

24.1

  1. Abbreviations: CCRT concomitant chemotherapy and radiotherapy, RS Radical Surgery, NACT neoadjuvant chemotherapy, RT radiotherapy. aPeople who were alive during follow-up. bPatients with local or distant metastasis
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us